These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11052423)

  • 1. Empiric therapy of community-acquired pneumonia.
    Green DS; San Pedro GS
    Semin Respir Infect; 2000 Sep; 15(3):227-33. PubMed ID: 11052423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of community-acquired pneumonia--IDSA guidelines. Infectious Diseases Society of America.
    Bernstein JM
    Chest; 1999 Mar; 115(3 Suppl):9S-13S. PubMed ID: 10084453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary on the 1993 American Thoracic Society guidelines for the treatment of community-acquired pneumonia.
    Campbell GD
    Chest; 1999 Mar; 115(3 Suppl):14S-18S. PubMed ID: 10084454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Lebanese Society for Infectious Diseases and Clinical Microbiology (LSIDCM) guidelines for adult community-acquired pneumonia (Cap) in Lebanon.
    Moghnieh R; Yared Sakr N; Kanj SS; Musharrafieh U; Husni R; Jradeh M; Al-Awar G; Matar M; Jureij W; Antoine S; Azar E; Abi Hanna P; Minari A; Hammoud J; Kfoury J; Mahfouz T; Abou Chakra D; Zaatari M; Tabbarah ZA;
    J Med Liban; 2014; 62(1):40-7. PubMed ID: 24684125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study.
    Carugati M; Aliberti S; Sotgiu G; Blasi F; Gori A; Menendez R; Encheva M; Gallego M; Leuschner P; Ruiz-Buitrago S; Battaglia S; Fantini R; Pascual-Guardia S; Marin-Corral J; Restrepo MI;
    Eur J Clin Microbiol Infect Dis; 2020 Aug; 39(8):1513-1525. PubMed ID: 32242314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hot Topics in Primary Care: Community-Acquired Bacterial Pneumonia: Is There Anything New?
    Liu H
    J Fam Pract; 2017 Apr; 66(4 Suppl):S10-S15. PubMed ID: 28375402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Old and new antibiotics for pediatric pneumonia.
    Bradley JS
    Semin Respir Infect; 2002 Mar; 17(1):57-64. PubMed ID: 11891519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real life management of community-acquired Pneumonia in adults in the Gulf region and comparison with practice guidelines: a prospective study.
    Mahboub B; Al Zaabi A; Al Ali OM; Ahmed R; Niederman MS; El-Bishbishi R
    BMC Pulm Med; 2015 Sep; 15():112. PubMed ID: 26424530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of community-acquired pneumonia in adults.
    Working Group of the South African Thoracic Society
    S Afr Med J; 2002 Aug; 92(8 Pt 2):647-55. PubMed ID: 12244941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial microbiologic studies did not affect outcome in adults hospitalized with community-acquired pneumonia.
    Sanyal S; Smith PR; Saha AC; Gupta S; Berkowitz L; Homel P
    Am J Respir Crit Care Med; 1999 Jul; 160(1):346-8. PubMed ID: 10390423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appropriate outpatient macrolide use in community-acquired pneumonia.
    Gotfried MH
    J Am Acad Nurse Pract; 2004 Apr; 16(4):146, 148, 150 passim. PubMed ID: 15137473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic resistance of pathogens causing community-acquired pneumonia.
    Feldman C; Anderson R
    Semin Respir Crit Care Med; 2012 Jun; 33(3):232-43. PubMed ID: 22718209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting risk of drug-resistant organisms in pneumonia: moving beyond the HCAP model.
    Webb BJ; Dascomb K; Stenehjem E; Dean N
    Respir Med; 2015 Jan; 109(1):1-10. PubMed ID: 25468412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic therapy for community-acquired pneumonia.
    Mandell LA
    Clin Chest Med; 1999 Sep; 20(3):589-98, ix. PubMed ID: 10516906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community-acquired pneumonia with risk for drug-resistant pathogens.
    Fleming V; Buck B; Nix N; Kumar P; Southwood R
    South Med J; 2013 Mar; 106(3):209-16. PubMed ID: 23462490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic testing to establish a microbial cause is helpful in the management of community-acquired pneumonia.
    Skerrett SJ
    Semin Respir Infect; 1997 Dec; 12(4):308-21. PubMed ID: 9436958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergency management of community-acquired bacterial pneumonia: what is new since the 2007 Infectious Diseases Society of America/American Thoracic Society guidelines.
    Moran GJ; Rothman RE; Volturo GA
    Am J Emerg Med; 2013 Mar; 31(3):602-12. PubMed ID: 23380120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
    Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS
    Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Empiric treatment of community-acquired pneumonia].
    Fálco Ferrer V; Almirante Gragera B; Pahissa Berga A
    Rev Clin Esp; 2004 Feb; 204(2):103-5. PubMed ID: 15023311
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of new therapies for severe community-acquired pneumonia.
    Restrepo MI; Anzueto A
    Curr Opin Infect Dis; 2006 Dec; 19(6):557-64. PubMed ID: 17075331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.